The mechanism of miR-124 involvement in Alzheimer’s disease (AD) mainly interfered with the clearance of the amyloid precursor protein and demonstrated that there was a negative regulatory relationship between miR-124 and BACE1 expression and that miR-124 could be a promising therapeutic target in patients with AD [85,86]. Here, BACE1 is linked to Alzheimer disease.